(SUNNYVALE, Calif.)Molecular diagnostics company Cepheid said Monday the Food and Drug Administration approved its new test aimed at detecting skin infections, including the antibiotic-resistant type...READ MORE
(NEW YORK)Shares of molecular diagnostics company Cepheid plunged Friday after the company reported a wider second-quarter loss and set a weak revenue outlook because of lower-than-expected ...READ MORE
(NEW YORK)A senior vice president at biotechnology company Cepheid exercised options for 60,000 shares of common stock, according to a Securities and Exchange Commission filing Friday.READ MORE
(SUNNYVALE, Calif.)Biotechnology company Cepheid said Thursday that its first-quarter loss narrowed on higher sales of its GeneXpert DNA testing systems and testing products.READ MORE